Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.

Papp-Wallace KM, Becka SA, Taracila MA, Winkler ML, Gatta JA, Rholl DA, Schweizer HP, Bonomo RA.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):777-88. doi: 10.1128/AAC.02073-15. Print 2016 Feb.

2.

The Burkholderia pseudomallei enoyl-acyl carrier protein reductase FabI1 is essential for in vivo growth and is the target of a novel chemotherapeutic with efficacy.

Cummings JE, Kingry LC, Rholl DA, Schweizer HP, Tonge PJ, Slayden RA.

Antimicrob Agents Chemother. 2014;58(2):931-5. doi: 10.1128/AAC.00176-13. Epub 2013 Nov 25.

3.

An improved selective culture medium enhances the isolation of Burkholderia pseudomallei from contaminated specimens.

Goodyear A, Strange L, Rholl DA, Silisouk J, Dance DAB, Schweizer HP, Dow S.

Am J Trop Med Hyg. 2013 Nov;89(5):973-982. doi: 10.4269/ajtmh.13-0119. Epub 2013 Sep 23.

4.

Proteomic analysis of colony morphology variants of Burkholderia pseudomallei defines a role for the arginine deiminase system in bacterial survival.

Chantratita N, Tandhavanant S, Wikraiphat C, Trunck LA, Rholl DA, Thanwisai A, Saiprom N, Limmathurotsakul D, Korbsrisate S, Day NP, Schweizer HP, Peacock SJ.

J Proteomics. 2012 Jan 4;75(3):1031-42. doi: 10.1016/j.jprot.2011.10.015. Epub 2011 Oct 28.

5.

Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.

Chantratita N, Rholl DA, Sim B, Wuthiekanun V, Limmathurotsakul D, Amornchai P, Thanwisai A, Chua HH, Ooi WF, Holden MT, Day NP, Tan P, Schweizer HP, Peacock SJ.

Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17165-70. doi: 10.1073/pnas.1111020108. Epub 2011 Oct 3.

6.

Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei.

Rholl DA, Papp-Wallace KM, Tomaras AP, Vasil ML, Bonomo RA, Schweizer HP.

Front Microbiol. 2011 Jul 1;2:139. doi: 10.3389/fmicb.2011.00139. eCollection 2011.

7.

In vitro activity of BAL30072 against Burkholderia pseudomallei.

Mima T, Kvitko BH, Rholl DA, Page MG, Desarbre E, Schweizer HP.

Int J Antimicrob Agents. 2011 Aug;38(2):157-9. doi: 10.1016/j.ijantimicag.2011.03.019. Epub 2011 May 18.

8.

Versatile dual-technology system for markerless allele replacement in Burkholderia pseudomallei.

López CM, Rholl DA, Trunck LA, Schweizer HP.

Appl Environ Microbiol. 2009 Oct;75(20):6496-503. doi: 10.1128/AEM.01669-09. Epub 2009 Aug 21.

9.

In vivo Himar1 transposon mutagenesis of Burkholderia pseudomallei.

Rholl DA, Trunck LA, Schweizer HP.

Appl Environ Microbiol. 2008 Dec;74(24):7529-35. doi: 10.1128/AEM.01973-08. Epub 2008 Oct 24.

Supplemental Content

Loading ...
Support Center